Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Il Yong | - |
dc.contributor.author | Lee, Jihyoun | - |
dc.contributor.author | Park, Suyeon | - |
dc.contributor.author | Lee, Jong Won | - |
dc.contributor.author | Youn, Hyun Jo | - |
dc.contributor.author | Hong, Jung Hwa | - |
dc.contributor.author | Hur, Ho | - |
dc.date.accessioned | 2021-08-11T11:43:34Z | - |
dc.date.available | 2021-08-11T11:43:34Z | - |
dc.date.issued | 2018-10-29 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5570 | - |
dc.description.abstract | Background: The National Health Insurance Service (NHIS) established a healthcare claim database for all Korean citizens. This study aimed to analyze the NHIS data and investigate the patterns of breast cancer treatments. Methods: We constructed a retrospective female breast cancer cohort by analyzing annual incident cases. The annual number of newly diagnosed female breast cancer was compared between the NHIS data and Korea National Cancer Incidence Database (KNCIDB). The annual treatment patterns including surgery, chemotherapy, radiation therapy, endocrine therapy and targeted therapy were analyzed. Results: A total of 148,322 women with newly diagnosed invasive breast cancer during 2006-2014 was identified. The numbers of newly diagnosed invasive breast cancer cases were similar between the NHIS data and KNCIDB, which demonstrated a strong correlation (r= 0.995; p< 0.001). The age distribution of the breast cancer cases in the NHIS data and KNCIDB also showed a strong correlation (r= 1.000; p< 0.001). About 85% of newly diagnosed breast cancer patients underwent operations. Although the proportions of chemotherapy use have not changed during 2006-2014, the total number of chemotherapy prescriptions sharply increased during this period. The proportions of radiotherapy and anti-hormonal therapy increased. Among the anti-hormonal agents, tamoxifen was the most frequently prescribed medication, and letrozole was the most preferred endocrine treatment in patients aged >= 50 years. Conclusion: Along with the increased breast cancer incidence in Korea, the frequencies of breast cancer treatments have increased. The NHIS data can be a feasible data source for future research. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한의학회 | - |
dc.title | Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3346/jkms.2018.33.e276 | - |
dc.identifier.scopusid | 2-s2.0-85055614652 | - |
dc.identifier.wosid | 000448562200003 | - |
dc.identifier.bibliographicCitation | Journal of Korean Medical Science, v.33, no.44 | - |
dc.citation.title | Journal of Korean Medical Science | - |
dc.citation.volume | 33 | - |
dc.citation.number | 44 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002396397 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordAuthor | Breast Neoplasms | - |
dc.subject.keywordAuthor | Database | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Incidence | - |
dc.subject.keywordAuthor | Population | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.